Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function.
Mol Pharm
; 20(4): 1884-1897, 2023 04 03.
Article
in En
| MEDLINE
| ID: mdl-36897792
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Tumor Necrosis Factor, Type I
/
Receptors, Tumor Necrosis Factor, Type II
Type of study:
Prognostic_studies
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United States